SABBY 13G LPCN 2.25.20

Company

Lipocine Inc.

Filed

February 25, 2020

Accession Number

0001535610-20-000075

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →